Cutting the National Institutes of Health budget by $5.8 billion as proposed by President Donald Trump would be a setback to dementia research and “is the last thing we should do,” Sen. Susan...
Social isolation, loneliness may harm cardiovascular, brain health
Aug 04, 2022
Social isolation and loneliness appear to be independent risk factors, but data on mediating pathways and confounders are limited.
Burden of neurologic diagnoses lower after COVID-19 versus flu
Mar 20, 2024
Postinfection incident neurologic diagnoses were observed in 2.79 and 4.91% of the COVID-19 and influenza cohorts, respectively.
Neurological conditions ranked as leading cause of disability-adjusted life years globally
Mar 15, 2024
Between 1990 and 2021, there was an 18.2 percent increase in the global DALY counts attributed to those conditions
COVID-19 linked to increased risk of neurological disorders
Jun 30, 2022
Most neurological disorders do not appear to be more frequent after COVID-19 than after influenza or bacterial pneumonia
Top 10 contributors to health loss in U.S.
By
Lois A. Bowers
Aug 31, 2015
A new analysis contains good and bad news regarding American life expectancy.
Technology-use changes essential to reducing loneliness ‘epidemic,’ surgeon general warns
By
John O'Connor
May 05, 2023
Reforming digital environments can help reduce a loneliness epidemic that disproportionately affects the elderly, according to US Surgeon General Vivek Murthy, MD.
Digital ‘communication bridge’ for seniors with aphasia is $13M closer to reality
By
Aaron Dorman
Mar 05, 2024
An upcoming research program will examine the potential for telehealth and wearable sensors to address a specific primary progressive aphasia.
17 percent of patients seeing neurologist travel long distance
Sep 13, 2023
Factors associated with long-distance travel include low neurologist density, rural setting and visits for ALS and nervous system cancer.
Second death in trial of experimental Alzheimer’s drug raising concerns
Nov 29, 2022
Doctors suspect that by stripping away amyloid deposits, lecanemab weakens blood vessels and leaves them vulnerable to bleeds.